跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Sitaglizen - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Sitaglizen
Approved
STANDARD
Sitaglizen
Magbro Healthcare Pvt. Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
267102f348785402
Company
Magbro Healthcare Pvt. Ltd
Type
Standard
Approval Details
Approval Id
267102f348785402
Drug Approval Philippines Name
Sitaglizen
Product Name
Sitaglizen
Registration Number
DRP-13645-04
Brand Name
Sitaglizen
Generic Name
Sitagliptin (as phosphate)
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg
Manufacturer
Magbro Healthcare Pvt. Ltd
Importer
Pharmakon Biotec Inc.
Distributor
Janamed Corporation
Issuance Date
27 October 2024
Expiry Date
22 March 2028
Pharmacologic Category
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
267102f348785402
Type
Standard
Back to Philippines FDA Approvals